Latest On Bioanalytical Systems, Inc (BASI):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-01-18 17:52 EST | News | Basis Global Technologies Starts U.S. IPO Effort | N/A |  |
| 2021-03-20 12:23 EST | News | Bioanalytical Systems announces name change to Inotiv (NOTV) | N/A | |
| 2021-03-18 12:11 EST | Analyst Rating | The Analyst Target Price has increased from $21 to $23. | Buy | |
| 2021-03-17 19:11 EST | News | Bioanalytical Systems to expand service offerings | N/A | |
| 2021-02-12 07:12 EST | Analyst Rating | The Analyst Target Price has increased from $17 to $21. | Buy | |
| 2021-02-10 11:10 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-10 07:26 EST | News | Bioanalytical Systems EPS beats by $0.16, beats on revenue | N/A | |
| 2021-02-10 07:25 EST | News | Bioanalytical Systems, Inc. (BASI) CEO Bob Leasure on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-02-10 07:12 EST | Earnings Estimate | An EPS average of -$0.07 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-01-27 07:11 EST | Earnings Estimate | An EPS average of -$0.08 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2021-01-02 15:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-23 15:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-23 15:17 EST | Earnings Estimate | An EPS average of $0.04 is estimated for the 2022 year. | Buy | |
| 2020-12-23 15:17 EST | Earnings Estimate | An EPS average of -$0.41 is estimated for the 2021 year. | Sell | |
| 2020-12-23 15:17 EST | Earnings Estimate | An EPS average of -$0.19 is estimated for the quarter ending on December 31, 2020. | Sell | |
| 2020-12-23 15:17 EST | Analyst Rating | The Analyst Target Price has increased from $2.15 to $17. | Buy | |
| 2020-12-22 11:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-21 23:13 EST | News | Bioanalytical Systems reports Q4 results | N/A | |
| 2020-12-13 03:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-15 11:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 17:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-24 00:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 12:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-20 16:17 EST | Insider Trade | John E Sagartz has directly acquired 3,733 shares and currently holds 634,232 shares. | Buy | |
| 2020-08-19 16:32 EST | Insider Trade | R Matthew Neff has directly acquired 5,000 shares and currently holds 60,350 shares. | Buy | |
| 2020-08-18 08:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-17 08:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 13:44 EST | News | Bioanalytical Systems reports Q3 results | N/A | |
| 2020-07-31 00:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 12:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-16 16:17 EST | Insider Trade | Robert Jr. Leasure has directly acquired 2,884 shares and currently holds 186,549 shares. | Buy | |
| 2020-06-11 17:21 EST | Insider Trade | Beth Taylor has directly acquired 10,000 shares and currently holds 23,300 shares. | Buy | |
| 2020-05-31 16:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-22 16:32 EST | Insider Trade | William D Pitchford has directly acquired 10,000 shares and currently holds 32,000 shares. | Buy | |
| 2020-05-21 19:31 EST | Insider Trade | Beth Taylor has directly acquired 3,300 shares and currently holds 13,300 shares. | Buy | |
| 2020-05-21 19:31 EST | Insider Trade | Beth Taylor has directly acquired 4,933 shares and currently holds 10,000 shares. | Buy | |
| 2020-05-21 19:31 EST | Insider Trade | Beth Taylor has directly acquired 5,067 shares and currently holds 5,067 shares. | Buy | |
| 2020-05-20 12:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-15 02:40 EST | News | Bioanalytical Systems reports Q2 results | N/A | |
| 2020-05-03 08:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-11 03:46 EST | News | Bioanalytical Systems reports Q1 results | N/A | |
| 2020-04-08 08:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-07 00:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 16:16 EST | Insider Trade | R Matthew Neff has directly acquired 10,000 shares and currently holds 55,350 shares. | Buy | |
| 2020-04-03 16:16 EST | Insider Trade | Richard Allen Johnson has directly acquired 10,000 shares and currently holds 40,000 shares. | Buy | |
| 2020-04-03 16:16 EST | Insider Trade | Gregory Cole Davis has directly acquired 10,000 shares and currently holds 30,000 shares. | Buy | |
| 2020-03-17 16:17 EST | Insider Trade | Robert Jr. Leasure has directly acquired 5,700 shares and currently holds 183,665 shares. | Buy | |
| 2020-03-16 16:32 EST | Insider Trade | R Matthew Neff has directly acquired 3,350 shares and currently holds 45,350 shares. | Buy | |
| 2020-03-16 16:32 EST | Insider Trade | R Matthew Neff has directly acquired 12,000 shares and currently holds 42,000 shares. | Buy | |
About Bioanalytical Systems, Inc (BASI):
Bioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
General
- Name Bioanalytical Systems, Inc
- Symbol BASI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 397
- Fiscal Year EndSeptember
- IPO Date1997-11-24
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://www.basinc.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 2.38
- Price/Book (Most Recent Quarter) 21.35
- Enterprise Value Revenue 2.96
- Enterprise Value EBITDA 86.2
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.21
- Next Year EPS Estimate $0.09
- Next Quarter EPS Estimate -$0.08
- Profit Margin -6%
- Operating Margin -1%
- Return on Assets -1%
- Return on Equity -41%
- Revenue 65.44 million
- Earnings Per Share -$0.12
- Revenue Per Share $5.98
- Gross Profit 18.24 million
- Quarterly Earnings Growth 38.5%
View More
Highlights
- Market Capitalization 167.19 million
- EBITDA 3.35 million
- Analyst Target Price $23
- Book Value Per Share $0.67
View More
Share Statistics
- Shares Outstanding 11.13 million
- Shares Float 5.92 million
- % Held by Insiders 3492%
- % Held by Institutions 10.67%
- Shares Short 57445
- Shares Short Prior Month 53484
- Short Ratio 0.53
- Short % of Float 1%
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 2
- 52 Week High $21.08
- 52 Week Low $3.05
- 50 Day Moving Average 15.53
- 200 Day Moving Average 9.43
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Bioanalytical Systems, Inc (BASI) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Bioanalytical Systems, Inc (BASI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-09 | $N/A | -$0.03 | -$0.19 | 84.21% |
| 2020-09-30 | 2020-12-21 | $N/A | -$0.16 | ||
| 2020-06-30 | 2020-08-14 | $N/A | -$0.08 | ||
| 2020-03-31 | 2020-06-30 | $16.01 million | -$0.08 | ||
| 2019-12-31 | 2020-03-31 | $12.92 million | -$0.05 | ||
| 2019-09-30 | 2019-12-31 | $14.79 million | -$0.13 | ||
| 2019-06-30 | 2019-09-30 | $10.86 million | $0.02 | ||
| 2019-03-31 | 2019-06-30 | $9.34 million | -$0.04 | ||
| 2018-12-31 | 2019-03-31 | $8.63 million | -$0.06 | ||
| 2018-09-30 | 2018-12-31 | $8.99 million | -$0.01 | ||
| 2018-06-30 | 2018-09-30 | $6.04 million | -$0.02 | ||
| 2018-03-31 | 2018-06-30 | $5.94 million | -$0.01 | ||
| 2017-12-31 | 2018-03-31 | $5.38 million | $0.01 | ||
| 2017-09-30 | 2017-12-31 | $5.87 million | $0.00 | ||
| 2017-06-30 | 2017-09-30 | $5.84 million | $0.02 | ||
| 2017-03-31 | 2017-06-30 | $6.36 million | $0.03 | ||
| 2016-12-31 | 2017-03-31 | $6.17 million | $0.05 | ||
| 2016-09-30 | 2016-12-31 | $5.15 million | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $5.05 million | -$0.25 | ||
| 2016-03-31 | 2016-06-30 | $5.34 million | -$0.05 | ||
| 2015-12-31 | 2016-03-31 | $4.9 million | -$0.03 | ||
| 2015-09-30 | 2015-12-31 | $4.98 million | -$0.06 | ||
| 2015-06-30 | 2015-09-30 | $6.15 million | -$0.10 | ||
| 2015-03-31 | 2015-06-30 | $5.73 million | $0.16 | ||
| 2014-12-31 | 2015-03-31 | $5.85 million | -$0.01 | ||
| 2014-09-30 | 2014-12-31 | $6.42 million | $0.01 | ||
| 2014-06-30 | 2014-09-30 | $6.03 million | -$0.05 | ||
| 2014-03-31 | 2014-06-30 | $5.91 million | $0.02 | ||
| 2013-12-31 | 2014-03-31 | $6.22 million | -$0.03 | ||
| 2013-09-30 | 2013-12-31 | $5.51 million | -$0.09 | ||
| 2013-06-30 | 2013-09-30 | $5.6 million | $0.03 | $0.00 | |
| 2013-03-31 | 2013-06-30 | $5.16 million | $0.07 | $0.01 | 600% |
| 2012-12-31 | 2013-03-31 | $5.8 million | -$0.04 | -$0.03 | -35.33% |
| 2012-09-30 | 2012-12-31 | $6.54 million | $0.03 | -$0.03 | 200% |
| 2012-06-30 | 2012-09-30 | $7.19 million | -$0.36 | -$0.14 | -160.43% |
| 2012-03-31 | 2012-06-30 | $6.97 million | -$0.03 | $0.07 | -148.43% |
| 2011-12-31 | 2012-03-31 | $7.52 million | -$0.26 | $0.06 | -533.33% |
| 2011-09-30 | 2011-12-31 | $8.15 million | -$0.22 | $0.04 | -656.75% |
| 2011-06-30 | 2011-09-30 | $8.48 million | -$0.10 | ||
| 2011-03-31 | 2011-06-30 | $8.42 million | -$0.65 | ||
| 2010-12-31 | 2011-03-31 | $8.09 million | $0.10 | ||
| 2010-09-30 | 2010-12-31 | $7.41 million | $0.06 | ||
| 2010-06-30 | 2010-08-16 | $8.06 million | $0.06 | ||
| 2010-03-31 | 2010-05-17 | $6.94 million | -$0.25 | ||
| 2009-12-31 | 2010-02-17 | $6.38 million | -$0.30 | ||
| 2009-06-30 | 2009-08-11 | $8.12 million | -$0.13 | ||
| 2009-03-31 | 2009-05-18 | $7.07 million | -$0.37 | ||
| 2008-12-31 | 2009-02-19 | $8.08 million | -$0.32 | ||
| 2008-09-30 | 2008-12-24 | $9.38 million | -$0.21 | ||
| 2008-06-30 | 2008-08-12 | $11.45 million | -$0.05 | ||
| 2008-03-31 | 2008-05-13 | $10.3 million | -$0.03 | ||
| 2007-12-31 | 2008-02-11 | $10.57 million | $-0.00 | ||
| 2007-09-30 | 2007-12-21 | $9.61 million | -$0.04 | ||
| 2007-06-30 | 2007-08-09 | $10.87 million | $0.09 | ||
| 2007-03-31 | 2007-05-08 | $8.39 million | $0.03 | ||
| 2006-12-31 | 2007-02-07 | $10.88 million | $0.11 | ||
| 2006-09-30 | 2006-11-29 | $10.75 million | -$0.14 | ||
| 2006-06-30 | 2006-08-15 | $10.04 million | -$0.34 | ||
| 2006-03-31 | 2006-05-10 | $12.42 million | $0.11 | ||
| 2005-12-31 | 2006-02-15 | $9.84 million | -$0.15 | ||
| 2005-06-30 | 2005-08-10 | $11.3 million | $0.07 | ||
| 2005-03-31 | 2005-05-11 | $9.14 million | -$0.18 | ||
| 2004-12-31 | 2005-02-15 | $9.69 million | $0.08 | ||
| 2004-09-30 | 2004-12-16 | $9.09 million | -$0.04 | ||
| 2004-06-30 | 2004-08-12 | $10.63 million | $0.12 | ||
| 2004-03-31 | 2004-04-28 | $8.65 million | -$0.10 | ||
| 2003-12-31 | 2004-02-12 | $8.78 million | -$0.03 | ||
| 2003-06-30 | 2003-08-12 | $7.87 million | $0.08 | -$0.02 | 500% |
| 2003-03-31 | 2003-05-20 | $6.95 million | -$0.04 | $0.06 | -166.67% |
| 2002-12-31 | 2003-02-11 | $6.97 million | $0.06 | $0.01 | 500% |
| 2002-09-30 | 2002-11-12 | $6.53 million | $0.00 | $0.06 | -100% |
| 2002-06-30 | 2002-08-06 | $6.58 million | $0.06 | $0.12 | -50% |
| 2002-03-31 | 2002-05-08 | $7.39 million | $0.11 | $0.11 | 0% |
| 2001-12-31 | 2002-02-05 | $6.02 million | $0.05 | $0.07 | -28.57% |
| 2001-09-30 | 2001-11-13 | $6.61 million | $0.10 | $0.08 | 25% |
| 2001-06-30 | 2001-08-01 | $6.4 million | $0.11 | $0.08 | 37.5% |
| 2001-03-31 | 2001-03-31 | $6.84 million | $0.13 | ||
| 2000-12-31 | 2001-01-29 | $5.43 million | $0.04 | $0.01 | 300% |
| 2000-09-30 | 2000-11-06 | $5.24 million | -$0.10 | $0.03 | -433.33% |
| 2000-06-30 | 2000-06-30 | $5.45 million | -$0.03 | ||
| 2000-03-31 | 2000-03-31 | $4.09 million | -$0.09 | ||
| 1999-12-31 | 1999-12-31 | -$0.08 | |||
| 1999-06-30 | 1999-08-05 | $0.01 | $0.01 | 0% | |
| 1999-03-31 | 1999-03-31 | $0.04 | |||
| 1998-12-31 | 1999-02-08 | $-0.00 | -$0.01 | 87% | |
| 1998-03-31 | 1998-05-07 | $0.05 | $0.06 | -16.67% |
Bioanalytical Systems, Inc (BASI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Bioanalytical Systems, Inc (BASI) Chart:
Bioanalytical Systems, Inc (BASI) News:
Below you will find a list of latest news for Bioanalytical Systems, Inc (BASI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Bioanalytical Systems, Inc (BASI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Bioanalytical Systems, Inc (BASI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920074166/0001104659-20-074166-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000091191618000169/0000911916-18-000169-index.htm |
| 2018-07-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/720154/000110465918044927/0001104659-18-044927-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465919061688/0001104659-19-061688-index.htm |
| 2019-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465919069262/0001104659-19-069262-index.htm |
| 2019-12-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/720154/000110465919076191/0001104659-19-076191-index.htm |
| 2020-01-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920000221/0001104659-20-000221-index.htm |
| 2020-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920007415/0001104659-20-007415-index.htm |
| 2020-01-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/720154/000110465920007622/0001104659-20-007622-index.htm |
| 2020-02-11 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/720154/000110465920016246/0001104659-20-016246-index.htm |
| 2020-02-14 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920021202/0001104659-20-021202-index.htm |
| 2020-02-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000110465920021555/0001104659-20-021555-index.htm |
| 2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920022275/0001104659-20-022275-index.htm |
| 2020-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920030208/0001104659-20-030208-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920030812/0001104659-20-030812-index.htm |
| 2020-03-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/720154/000110465920031425/0001104659-20-031425-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920036645/0001104659-20-036645-index.htm |
| 2020-03-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920041165/0001104659-20-041165-index.htm |
| 2020-04-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/720154/000110465920043686/0001104659-20-043686-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920051020/0001104659-20-051020-index.htm |
| 2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000110465920061465/0001104659-20-061465-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920062667/0001104659-20-062667-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920074166/0001104659-20-074166-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000110465920095412/0001104659-20-095412-index.htm |
| 2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920105595/0001104659-20-105595-index.htm |
| 2020-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000110465920106565/0001104659-20-106565-index.htm |
| 2018-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418016558/0001144204-18-016558-index.htm |
| 2018-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418023748/0001144204-18-023748-index.htm |
| 2018-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418028600/0001144204-18-028600-index.htm |
| 2018-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000114420418028903/0001144204-18-028903-index.htm |
| 2018-07-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418037096/0001144204-18-037096-index.htm |
| 2018-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418044329/0001144204-18-044329-index.htm |
| 2018-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000114420418044596/0001144204-18-044596-index.htm |
| 2018-09-14 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418049499/0001144204-18-049499-index.htm |
| 2018-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418052490/0001144204-18-052490-index.htm |
| 2018-12-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/720154/000114420418064086/0001144204-18-064086-index.htm |
| 2018-12-21 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/720154/000114420418066005/0001144204-18-066005-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420418066044/0001144204-18-066044-index.htm |
| 2019-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419001833/0001144204-19-001833-index.htm |
| 2019-01-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/720154/000114420419003200/0001144204-19-003200-index.htm |
| 2019-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419007666/0001144204-19-007666-index.htm |
| 2019-02-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000114420419008031/0001144204-19-008031-index.htm |
| 2019-02-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419008624/0001144204-19-008624-index.htm |
| 2019-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419015864/0001144204-19-015864-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419024240/0001144204-19-024240-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000114420419026634/0001144204-19-026634-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419027195/0001144204-19-027195-index.htm |
| 2019-07-15 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419034665/0001144204-19-034665-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/720154/000114420419039896/0001144204-19-039896-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/720154/000114420419040010/0001144204-19-040010-index.htm |
| 2018-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911018002372/0001179110-18-002372-index.htm |
| 2018-05-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911018006434/0001179110-18-006434-index.htm |
| 2018-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911018011334/0001179110-18-011334-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911018011494/0001179110-18-011494-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911018011495/0001179110-18-011495-index.htm |
| 2019-01-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019000758/0001179110-19-000758-index.htm |
| 2019-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019000759/0001179110-19-000759-index.htm |
| 2019-02-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001759/0001179110-19-001759-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001761/0001179110-19-001761-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001762/0001179110-19-001762-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001763/0001179110-19-001763-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001764/0001179110-19-001764-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001765/0001179110-19-001765-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001766/0001179110-19-001766-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001767/0001179110-19-001767-index.htm |
| 2019-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019001768/0001179110-19-001768-index.htm |
| 2019-02-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019002629/0001179110-19-002629-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019002814/0001179110-19-002814-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019002928/0001179110-19-002928-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019002935/0001179110-19-002935-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019003254/0001179110-19-003254-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019003514/0001179110-19-003514-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019003681/0001179110-19-003681-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019003682/0001179110-19-003682-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019003846/0001179110-19-003846-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019003848/0001179110-19-003848-index.htm |
| 2019-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019004044/0001179110-19-004044-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019005148/0001179110-19-005148-index.htm |
| 2019-05-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019006886/0001179110-19-006886-index.htm |
| 2019-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019007398/0001179110-19-007398-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019007458/0001179110-19-007458-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019007617/0001179110-19-007617-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019007691/0001179110-19-007691-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019007692/0001179110-19-007692-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019007694/0001179110-19-007694-index.htm |
| 2019-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019009701/0001179110-19-009701-index.htm |
| 2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019009836/0001179110-19-009836-index.htm |
| 2019-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010013/0001179110-19-010013-index.htm |
| 2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010112/0001179110-19-010112-index.htm |
| 2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010151/0001179110-19-010151-index.htm |
| 2019-09-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010153/0001179110-19-010153-index.htm |
| 2019-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010154/0001179110-19-010154-index.htm |
| 2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010235/0001179110-19-010235-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010361/0001179110-19-010361-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010362/0001179110-19-010362-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019010363/0001179110-19-010363-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019012355/0001179110-19-012355-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019012356/0001179110-19-012356-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019012357/0001179110-19-012357-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019012358/0001179110-19-012358-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019012359/0001179110-19-012359-index.htm |
| 2019-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911019012360/0001179110-19-012360-index.htm |
| 2020-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020000864/0001179110-20-000864-index.htm |
| 2020-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020001949/0001179110-20-001949-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020002016/0001179110-20-002016-index.htm |
| 2020-03-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020003553/0001179110-20-003553-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020003699/0001179110-20-003699-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020003795/0001179110-20-003795-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020004615/0001179110-20-004615-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020004617/0001179110-20-004617-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020004618/0001179110-20-004618-index.htm |
| 2020-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020006457/0001179110-20-006457-index.htm |
| 2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020006467/0001179110-20-006467-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020007222/0001179110-20-007222-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020007415/0001179110-20-007415-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020009168/0001179110-20-009168-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000117911020009187/0001179110-20-009187-index.htm |
| 2019-04-25 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/720154/000119312519117524/0001193125-19-117524-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000174618819000002/0001746188-19-000002-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000174618819000003/0001746188-19-000003-index.htm |
| 2018-07-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000174620118000001/0001746201-18-000001-index.htm |
| 2018-07-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000174620118000002/0001746201-18-000002-index.htm |
| 2018-07-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/720154/000174620118000003/0001746201-18-000003-index.htm |
| 2019-07-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/720154/999999999719006288/9999999997-19-006288-index.htm |
Bioanalytical Systems, Inc (BASI) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bioanalytical Systems, Inc (BASI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 3492%Institutional Ownership: 1067%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-05-20 | Beth Taylor | VP- Finance & CFO | Buy | 4,933.00 | 4.42 | 21,803.86 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020006457/0001179110-20-006457-index.htm |
| 2019-05-29 | Gregory Cole Davis | Director | Buy | 5,000.00 | 1.99 | 9,950.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019006886/0001179110-19-006886-index.htm |
| 2019-09-10 | Wendy Perrow | Director | Buy | 10,000.00 | 3.62 | 36,200.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010235/0001179110-19-010235-index.htm |
| 2019-08-28 | William D Pitchford | Chief HR Officer | Buy | 10,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010154/0001179110-19-010154-index.htm | ||
| 2019-06-06 | Robert Jr. Leasure | President and CEO | Buy | 1,000.00 | 1.95 | 1,950.00 | 100,615.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007398/0001179110-19-007398-index.htm |
| 2018-09-14 | PETER KISSINGER | 10% Share Holder | Buy | 10,000.00 | 1.74 | 17,382.00 | 1,033,457.00 | https://www.sec.gov/Archives/edgar/data/720154/000091191618000169/0000911916-18-000169-index.htm |
| 2019-06-07 | Robert Jr. Leasure | President and CEO | Buy | 5,000.00 | 1.96 | 9,800.00 | 105,615.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007398/0001179110-19-007398-index.htm |
| 2019-06-12 | Robert Jr. Leasure | President and CEO | Buy | 4.00 | 1.94 | 7.76 | 105,619.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007692/0001179110-19-007692-index.htm |
| 2019-02-27 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 10,826.00 | 1.53 | 16,563.78 | 10,826.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019002814/0001179110-19-002814-index.htm |
| 2019-03-01 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 125.00 | 1.54 | 192.50 | 10,951.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019003254/0001179110-19-003254-index.htm |
| 2019-06-13 | Robert Jr. Leasure | President and CEO | Buy | 5,000.00 | 1.97 | 9,850.00 | 110,619.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007692/0001179110-19-007692-index.htm |
| 2018-09-12 | R Matthew Neff | Director | Buy | 2,500.00 | 1.65 | 4,125.00 | 12,500.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911018011495/0001179110-18-011495-index.htm |
| 2019-08-19 | Robert Jr. Leasure | President and CEO | Buy | 16,000.00 | 2.19 | 35,040.00 | 126,619.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019009701/0001179110-19-009701-index.htm |
| 2019-12-02 | Joseph Earl Flynn | Chief Commercial Officer | Buy | 2,564.00 | 127,514.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019012357/0001179110-19-012357-index.htm | ||
| 2018-09-13 | Jill Blumhoff | VP, Finance & CFO | Buy | 450.00 | 1.62 | 729.00 | 1,311.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911018011494/0001179110-18-011494-index.htm |
| 2020-05-21 | Beth Taylor | VP- Finance & CFO | Buy | 3,300.00 | 4.52 | 14,916.00 | 13,300.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020006457/0001179110-20-006457-index.htm |
| 2019-09-04 | Robert Jr. Leasure | President and CEO | Buy | 11,500.00 | 3.15 | 36,225.00 | 138,119.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010112/0001179110-19-010112-index.htm |
| 2019-05-30 | Gregory Cole Davis | Director | Buy | 5,000.00 | 1.96 | 9,800.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019006886/0001179110-19-006886-index.htm |
| 2018-09-14 | R Matthew Neff | Director | Buy | 2,500.00 | 1.66 | 4,150.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911018011495/0001179110-18-011495-index.htm |
| 2018-02-16 | Philip A Downing | Sr. VP, Preclinical Srvcs. | Buy | 5,000.00 | 1.46 | 7,300.00 | 15,765.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911018002372/0001179110-18-002372-index.htm |
| 2019-09-13 | Robert Jr. Leasure | President and CEO | Buy | 26,846.00 | 3.72 | 99,867.12 | 164,965.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010363/0001179110-19-010363-index.htm |
| 2020-01-27 | Robert Jr. Leasure | President and CEO | Buy | 13,000.00 | 177,965.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020000864/0001179110-20-000864-index.htm | ||
| 2019-06-11 | Jill Blumhoff | VP, Finance & CFO | Buy | 500.00 | 1.98 | 990.00 | 1,811.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007617/0001179110-19-007617-index.htm |
| 2020-03-16 | Robert Jr. Leasure | President and CEO | Buy | 5,700.00 | 3.49 | 19,893.00 | 183,665.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020003795/0001179110-20-003795-index.htm |
| 2020-06-15 | Robert Jr. Leasure | President and CEO | Buy | 2,884.00 | 5.20 | 14,996.80 | 186,549.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020007415/0001179110-20-007415-index.htm |
| 2019-05-31 | Gregory Cole Davis | Director | Buy | 5,000.00 | 2.00 | 10,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019006886/0001179110-19-006886-index.htm |
| 2019-03-08 | R Matthew Neff | Director | Buy | 5,715.00 | 1.75 | 10,001.25 | 20,715.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019003681/0001179110-19-003681-index.htm |
| 2018-09-11 | Philip A Downing | Sr. VP, Preclinical Srvcs. | Buy | 5,000.00 | 1.67 | 8,350.00 | 20,765.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911018011334/0001179110-18-011334-index.htm |
| 2019-03-06 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 10,000.00 | 1.75 | 17,500.00 | 20,951.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019003514/0001179110-19-003514-index.htm |
| 2019-03-15 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 1.00 | 1.90 | 1.90 | 20,952.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019004044/0001179110-19-004044-index.htm |
| 2019-09-13 | William D Pitchford | Chief HR Officer | Buy | 12,000.00 | 3.70 | 44,400.00 | 22,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010361/0001179110-19-010361-index.htm |
| 2019-06-13 | R Matthew Neff | Director | Buy | 1,410.00 | 1.98 | 2,791.80 | 22,125.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007694/0001179110-19-007694-index.htm |
| 2019-12-02 | Michael Baim | VP Bioanalytical Services | Buy | 7,718.00 | 22,718.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019012355/0001179110-19-012355-index.htm | ||
| 2020-06-10 | Beth Taylor | VP- Finance & CFO | Buy | 10,000.00 | 23,300.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020007222/0001179110-20-007222-index.htm | ||
| 2019-02-19 | John E Sagartz | Director | Buy | 2,500.00 | 1.43 | 3,575.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019002935/0001179110-19-002935-index.htm |
| 2019-06-10 | Philip A Downing | Sr. VP, Preclinical Srvcs. | Buy | 5,000.00 | 1.96 | 9,800.00 | 25,765.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007458/0001179110-19-007458-index.htm |
| 2019-06-14 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 7,500.00 | 1.99 | 14,925.00 | 28,452.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019007691/0001179110-19-007691-index.htm |
| 2020-04-01 | Gregory Cole Davis | Director | Buy | 10,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020004618/0001179110-20-004618-index.htm | ||
| 2020-02-20 | R Matthew Neff | Director | Buy | 9,458.00 | 4.60 | 43,506.80 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020002016/0001179110-20-002016-index.htm |
| 2020-02-20 | Richard Allen Johnson | Director | Buy | 20,000.00 | 4.63 | 92,600.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020001949/0001179110-20-001949-index.htm |
| 2019-08-23 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 2,594.00 | 2.77 | 7,185.38 | 31,046.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019009836/0001179110-19-009836-index.htm |
| 2020-05-21 | William D Pitchford | Chief HR Officer | Buy | 10,000.00 | 4.47 | 44,700.00 | 32,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020006467/0001179110-20-006467-index.htm |
| 2019-12-02 | Philip A Downing | Sr. VP, Preclinical Srvcs. | Buy | 8,436.00 | 34,201.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019012356/0001179110-19-012356-index.htm | ||
| 2019-08-29 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 5,000.00 | 2.69 | 13,450.00 | 36,046.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010013/0001179110-19-010013-index.htm |
| 2019-03-14 | John E Sagartz | Director | Buy | 1,400.00 | 1.94 | 2,716.00 | 3,900.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019003848/0001179110-19-003848-index.htm |
| 2020-04-01 | Richard Allen Johnson | Director | Buy | 10,000.00 | 40,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020004617/0001179110-20-004617-index.htm | ||
| 2020-03-12 | R Matthew Neff | Director | Buy | 12,000.00 | 3.80 | 45,600.00 | 42,000.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020003699/0001179110-20-003699-index.htm |
| 2020-03-13 | R Matthew Neff | Director | Buy | 3,350.00 | 3.93 | 13,165.50 | 45,350.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020003699/0001179110-20-003699-index.htm |
| 2019-09-05 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 10,500.00 | 3.45 | 36,225.00 | 45,546.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010151/0001179110-19-010151-index.htm |
| 2019-09-06 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 2,000.00 | 3.35 | 6,700.00 | 47,546.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010151/0001179110-19-010151-index.htm |
| 2019-09-13 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 1,000.00 | 3.65 | 3,650.00 | 48,546.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019010362/0001179110-19-010362-index.htm |
| 2020-05-19 | Beth Taylor | VP- Finance & CFO | Buy | 5,067.00 | 4.38 | 22,193.46 | 5,067.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020006457/0001179110-20-006457-index.htm |
| 2020-04-01 | R Matthew Neff | Director | Buy | 10,000.00 | 55,350.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020004615/0001179110-20-004615-index.htm | ||
| 2019-12-02 | Daniel Thomas Oakley | Chief Operating Officer | Buy | 8,974.00 | 57,520.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019012358/0001179110-19-012358-index.htm | ||
| 2020-08-19 | R Matthew Neff | Director | Buy | 5,000.00 | 4.75 | 23,750.00 | 60,350.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020009168/0001179110-20-009168-index.htm |
| 2019-01-14 | Robert Jr. Leasure | President and CEO | Buy | 34,615.00 | 60,715.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019000759/0001179110-19-000759-index.htm | ||
| 2019-12-02 | John E Sagartz | Director | Buy | 8,974.00 | 630,499.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019012360/0001179110-19-012360-index.htm | ||
| 2020-08-19 | John E Sagartz | Chief Strategy Officer | Buy | 3,733.00 | 4.75 | 17,731.75 | 634,232.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911020009187/0001179110-20-009187-index.htm |
| 2019-01-14 | Robert Jr. Leasure | President and CEO | Buy | 10,000.00 | 70,715.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019000759/0001179110-19-000759-index.htm | ||
| 2019-02-28 | Robert Jr. Leasure | President and CEO | Buy | 8,900.00 | 1.51 | 13,439.00 | 79,615.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019002928/0001179110-19-002928-index.htm |
| 2019-12-02 | Jill Blumhoff | VP, Finance & CFO | Buy | 7,000.00 | 8,811.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019012359/0001179110-19-012359-index.htm | ||
| 2019-03-01 | Robert Jr. Leasure | President and CEO | Buy | 10,000.00 | 1.62 | 16,200.00 | 89,615.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019002928/0001179110-19-002928-index.htm |
| 2019-03-08 | Robert Jr. Leasure | President and CEO | Buy | 4,000.00 | 1.77 | 7,080.00 | 93,615.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019003682/0001179110-19-003682-index.htm |
| 2019-03-12 | Robert Jr. Leasure | President and CEO | Buy | 6,000.00 | 1.94 | 11,640.00 | 99,615.00 | https://www.sec.gov/Archives/edgar/data/720154/000117911019003846/0001179110-19-003846-index.htm |